Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tracking PDUFA V: Making a good thing better

This article was originally published in SRA

Executive Summary

Negotiations for the fifth round of the Prescription Drug User Fee Act (PDUFA V) went unprecedentedly smoothly. Nevertheless, the trade groups representing the biopharmaceutical industry are looking to make a good thing better, introducing of a new tracking system aimed at ensuring drug makers have sustained engagement with the Food and Drug Administration throughout the drug application review process.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS117410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel